BIIB122
283PD201
Phase 3 small_molecule active
Quick answer
BIIB122 for Parkinson Disease is a Phase 3 program (small_molecule) at Denali Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Denali Therapeutics
- Indication
- Parkinson Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active